APA (7th ed.) Citation

Gulati, A., Reidy, D., Halim, A., Mashayekhi, K., Imagawa, D. K., & Halperin, D. M. (2026). Clinical Validity of NETest2.0 ® in Surveillance of Neuroendocrine Tumor Patients: Evidence from a NET Registry Study (NCT02270567). Cancers, 18(9), 1457. https://doi.org/10.3390/cancers18091457

Chicago Style (17th ed.) Citation

Gulati, Anthony, Diane Reidy, Abdel Halim, Kiarash Mashayekhi, David K. Imagawa, and Daniel M. Halperin. "Clinical Validity of NETest2.0 ® in Surveillance of Neuroendocrine Tumor Patients: Evidence from a NET Registry Study (NCT02270567)." Cancers 18, no. 9 (2026): 1457. https://doi.org/10.3390/cancers18091457.

MLA (9th ed.) Citation

Gulati, Anthony, et al. "Clinical Validity of NETest2.0 ® in Surveillance of Neuroendocrine Tumor Patients: Evidence from a NET Registry Study (NCT02270567)." Cancers, vol. 18, no. 9, 2026, p. 1457, https://doi.org/10.3390/cancers18091457.